Author Profile

Erin Podolak, MA

Managing Editor

Erin Podolak

Erin Podolak, MA, is Managing Editor, Scientific Communication in the Strategic Communication Education and Outreach Department at St. Jude.

Stories by Erin Podolak

St. Jude On

There from the beginning: The evolution of HIV research and care at St. Jude

Erin Podolak, MA

Research and care for HIV has shifted over time, but St. Jude has always been at the forefront.

Investigator Insights

5 Questions for Jason Rosch, PhD

Erin Podolak, MA and Jason Rosch, PhD

Learn what inspired Jason Rosch, PhD, to a career in science studying host-pathogen interactions.

Investigator Insights

5 Questions for Heather Conklin, PhD

Erin Podolak, MA and Heather Conklin, PhD

Learn about what drives Heather Conklin, PhD, to study cognitive function and cognitive rehabilitation strategies in childhood brain tumor survivors.

St. Jude On

Tailoring treatment for bone marrow failure syndromes

Erin Podolak, MA

Learn more about how the bone marrow failure team integrate science and care.

Research

Addressing treatment-related mortality: Student’s research spotlights need for supportive care

Erin Podolak, MA

Gathering data increases understanding of treatment-related mortality in low- and middle-income countries.

St. Jude On

Targeted protein degradation to treat cancer

Erin Podolak, MA

St. Jude scientists are degrading proteins to treat cancer.

Research

Targeting DNA damage repair gives radiation therapy a boost

Erin Podolak, MA

Inhibiting DNA damage repair alongside radiation therapy can treat brain tumors.

Research

Metastatic cancer cells thrive in harsh microenvironments

Erin Podolak, MA

Like a journey through space, metastatic cells have to adapt to spread throughout the body.

Research

Data-driven science helps researchers design new protein interactions

Erin Podolak, MA

With a comprehensive approach to thinking about data, St. Jude scientists are fueling progress.

Research

Liver toxicity and ALL: Genomics drive variability between patients

Erin Podolak, MA

Research reveals how inherited genetic variants can contribute to liver toxicity after chemotherapy.